文献速递真菌感染艾滋病与性传播感染结核与非结核分枝杆菌

拉丁美洲HIV相关组织胞浆菌病与结核病负担比较:一项模型研究

Burden of HIV-associated histoplasmosis compared with tuberculosis in Latin America: a modelling study.
PubMed 文献 · Lancet Infect Dis · 2018-08-23

该模型研究基于历史组织胞浆菌素皮肤试验文献、WHO结核通报数据和UNAIDS报告,估算2012年拉丁美洲HIV相关组织胞浆菌病与结核病的疾病负担。研究纳入24篇文章共129项皮肤试验研究,估计HIV相关组织胞浆菌病发病数范围为6710至15657例,死亡数范围为671至9394例,而结核病死亡数为5062例。作者认为在拉丁美洲HIV感染者中,组织胞浆菌病的发病负担与结核病相当,死亡负担甚至更高。

要点

  • 2012年拉丁美洲HIV相关组织胞浆菌病发病数估计为6710至15657例,死亡数估计为671至9394例。
  • 同期拉丁美洲报告的HIV相关结核病死亡数为5062例(95%CI 3777-6405)。
  • 组织胞浆菌病高流行区(>30%)和高发病区(>1.5例/100 HIV感染者)为中美洲、南美洲最北部和阿根廷。

核心结论

  • 在拉丁美洲HIV感染者中,组织胞浆菌病的发病负担与结核病相当,死亡负担甚至更高。

研究设计与样本

  • 本研究为模型研究,基于文献检索到的历史组织胞浆菌素皮肤试验研究(抗原稀释度>1/10)估算一般人群暴露流行率,结合WHO结核通报数据和2012年UNAIDS报告数据,估算2012年拉丁美洲各国HIV相关组织胞浆菌病年发病数和死亡数,并在估计全过程系统传播不确定性。
  • 截至2015年6月1日检索到1310篇文章,最终纳入24篇文章,代表129项在拉丁美洲国家一般人群中开展的组织胞浆菌素皮肤试验研究。

主要发现

  • 2012年拉丁美洲HIV相关组织胞浆菌病发病数估计范围为6710例(95%CI 5680-7867)至15657例(95%CI 13254-18357)。
  • 组织胞浆菌病患病率>30%和发病率>1.5例/100 HIV感染者的高发地区为中美洲、南美洲最北部和阿根廷。
  • 根据现实情景,组织胞浆菌病相关死亡数估计范围为671例(95%CI 568-787)至9394例(95%CI 7952-11014),而拉丁美洲报告的结核病相关死亡数为5062例(95%CI 3777-6405)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fungal infections remain a major contributor to the opportunistic infections that affect people living with HIV. Among them, histoplasmosis is considered neglected, often being misdiagnosed as tuberculosis, and is responsible for numerous deaths in Latin America. The objective of this study was to estimate the burden of HIV-associated histoplasmosis compared with tuberculosis in Latin American countries. METHODS: For this modelling study, we estimated prevalence of previous exposure to Histoplasma capsulatum, HIV-associated histoplasmosis annual incidence, and number of deaths in 2012 in Latin American countries based on historical histoplasmin skin test studies in the general population, with an antigen dilution level of more than 1/10. Studies were identified in a literature search. Data on HIV-associated tuberculosis were extracted from the WHO notifications and outcomes tables and data on people living with HIV were extracted from the UNAIDS report for the year 2012. We systematically propagated uncertainty throughout all the steps of the estimation process. FINDINGS: Among 1310 articles identified as of June 1, 2015, 24 articles were included in the study, representing 129 histoplasmin skin test studies led in the general population of Latin American countries. For the year 2012, we estimated a range of 6710 (95% CI 5680-7867) to 15 657 (13 254-18 357) cases of symptomatic HIV-associated histoplasmosis in Latin America. Hotspot areas for histoplasmosis prevalence (>30%) and incidence (>1·5 cases per 100 people living with HIV) were Central America, the northernmost part of South America, and Argentina. According to realistic scenarios, we estimated a range of 671 (95% CI 568-787) to 9394 (7952-11 014) deaths related to histoplasmosis, compared with 5062 (3777-6405) deaths related to tuberculosis reported in Latin America. INTERPRETATION: Our estimates of histoplasmosis incidence and deaths are high and consistent with published data. For the first time, the burden of histoplasmosis is estimated to be equivalent in incidence and even higher in deaths when compared with tuberculosis among people living with HIV in Latin America. FUNDING: None.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Adenis AA, Valdes A, Cropet C, et al. Burden of HIV-associated histoplasmosis compared with tuberculosis in Latin America: a modelling study. Lancet Infect Dis. 2018. PMID: 30146320. doi:10.1016/S1473-3099(18)30354-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。